GIP
GBT

Granite Investment Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Granite Investment Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,582
Closed -$3.52M – 290
2021
Q2 		$3.52M Buy
100,582
+826
+0.8% +$32.2K 0.11% 171
2021
Q1 		$4.07M Buy
99,756
+3,851
+4% +$177K 0.14% 147
2020
Q4 		$4.15M Buy
+95,905
New +$4.73M 0.15% 136

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Granite Investment Partners's GBT Position: Q3 2021 in Review

Granite Investment Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 100,582 shares — an estimated $3.52M sold.

Granite Investment Partners first reported a position in GBT in Q4 2020 and held it in 3 quarters. The position peaked at $4.15M in Q4 2020. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Granite Investment Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Granite Investment Partners sold 100,582 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $3.52M.
  • Granite Investment Partners first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • Granite Investment Partners's Global Blood Therapeutics, Inc. position peaked at $4.15M in Q4 2020.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Granite Investment Partners's 13F filing for Q3 2021, filed 3 Nov 2021.